Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool aims to better measure psoriasis burden over a lifetime

NCT ID NCT05959070

Completed Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new questionnaire called DermCLCI-p to see if it accurately measures the long-term life impacts of moderate-to-severe psoriasis. 154 adults starting the medication risankizumab filled out the 30-question survey over 28 weeks. The goal was to validate the tool for future use in research and clinics, not to test the drug itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Locations

  • Cliniques Universitaires UCL Saint-Luc /ID# 253234

    Brussels, Brussels Capital, 1200, Belgium

  • Dermatologie Maldegem /ID# 252454

    Maldegem, Oost-Vlaanderen, 9990, Belgium

  • Dermatologische Praxis Dr. med. Marvin Kuske /ID# 265688

    Dresden, 01109, Germany

  • Dermatrials Research /ID# 253879

    Hamilton, Ontario, L8N 1Y2, Canada

  • Dre Angelique Gagne-Henley M.D. inc. /ID# 262591

    Saint-Jérôme, Quebec, J7Z 7E2, Canada

  • Gemeinschaftspraxis Dres. Anika Hünermund/Mario Pawlak /ID# 255874

    Heilbad Heiligenstadt, 37308, Germany

  • Hautarztpraxis Mortazawi /ID# 255872

    Remscheid, North Rhine-Westphalia, 42897, Germany

  • JRB Research /ID# 253877

    Ottawa, Ontario, K1H 7X3, Canada

  • Lynde Institute for Dermatology /ID# 253876

    Markham, Ontario, L3P 1X2, Canada

  • Praxis Dres. Wiemers/Wiemers /ID# 255873

    Leipzig, 04317, Germany

  • SKiN Centre for Dermatology /ID# 255882

    Peterborough, Ontario, K9J 5K2, Canada

  • UZ Gent /ID# 252458

    Ghent, Oost-Vlaanderen, 9000, Belgium

  • Universitaetsklinikum Hamburg-Eppendorf /ID# 254340

    Hamburg, 20246, Germany

  • Universitair Ziekenhuis Leuven /ID# 252457

    Leuven, Vlaams-Brabant, 3000, Belgium

  • Universite Libre de Bruxelles - Hopital Erasme /ID# 252456

    Anderlecht, Brussels Capital, 1070, Belgium

  • Wiseman Dermatology Research /ID# 255883

    Winnipeg, Manitoba, R3M 3Z4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.